Check out our protocol for streamlined isolation and immunophenotyping of leukocytes from various mouse tissues! Excited to implement these in our in vivo mouse models to better understand the immune system and harness it for safe and effective immunotherapies. @um-radyfhs.bsky.social

Join us for the last CHRIM Research Rounds of the termon Dec 1st! We'll hear from Dr. Yale Michaels and Huda Alfarekh, sharing their presentation "Broadening access to genetically modified cell therapies through cost-effective manufacturing." See you there! #RPOMISE #CHRIM #CCMB

Highlights from a wonderful #CCRC2025. Thank you to the organizers for the opportunity to give a lightning talk on our work in creating better and safer CAR T cell therapies. It was a fruitful 3 days of networking and great science! The future of cancer care is alive in 🇨🇦

Interested in using single cell technologies to unravel the molecular origins and evolution of ovarian cancer? We are looking for a graduate student! More details here 👇

If you are a Canadian Researcher, faculty member, RA, PDF or graduate student in Canada please consider signing our letter to ask for increase of funding in research to make Canada a leader in science and build a stronger economy. docs.google.com/document/d/1...

That's a wrap for this year's BioCanRx #Summit4CI! Here are some "bites" from Canada's Immunotherapy network from the lens of a Learning Institute Scholar— a thread. #oncosky #cansky #immunosky

Thanks @umbmg.bsky.social! Looking forward to connecting with folks attending #BioCanRx #Summit4CI this weekend!

Design of sensitive monospecific and bispecific synthetic chimeric TCRs for cancer therapy @naturecancer.bsky.social @sylvainsimon.bsky.social www.nature.com/articles/s43...

It's 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗗𝗮𝘆 𝗼𝗳 𝗪𝗼𝗺𝗲𝗻 𝗮𝗻𝗱 𝗚𝗶𝗿𝗹𝘀 𝗶𝗻 𝗦𝗰𝗶𝗲𝗻𝗰𝗲. I only know because this is being shared a lot across all platforms.

Today is #WorldCancerDay Did you know❓ Vaccination against #hepatitisB can help prevent liver cancer in children, while #HPV vaccination for young girls can reduce the risk of #CervicalCancer later in life. Learn more 👉bit.ly/2NeFF8B

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies in 783 Patients (38 clinical trials) -Analysis in 169 patients = no pathological insertions linked to secondary malignancies -Highlights safety of vector gene engineered T cell therapies www.nature.com/articles/s41...

#NCB2024 In July, @tamraogilvie.bsky.social, Taylor, @olivier-saulnier.bsky.social & co reported a noncanonical role for OTX2 in regulating #AlternativeSplicing and a stem cell and pro-tumorigenic splicing program in group 3 #medulloblastoma. www.nature.com/articles/s41...

The Department of Biochemistry and Medical Genetics at the University of Manitoba is excited to join BlueSky! Follow us for updates on our groundbreaking research, departmental achievements, and latest developments in the field! Find out more about more here: umanitoba.ca/medicine/dep...

Hello! We are the Pediatric Research in Oncology in #Manitoba: Innovation, Science, Excellence (PROMISE) theme, a dedicated research group established through the Children's Hospital Research Institute of Manitoba (CHRIM) and CancerCare Manitoba (CCMB).

I've made a starter pack for the department of Biochem and Med Genetics at the University of Manitoba Rady Faculty of Health Sciences. Comment if you'd like me to add you. Please feel free to share with others. go.bsky.app/PH1RXXX

Let's build a starter pack for childhood cancer research. Please send a message to be added! 🎗️ go.bsky.app/Tpd9QnM

Both #Cancer #Research starter packs are now completely full! ~300 researchers, oncologists, students, postdocs, patient advocates, and organizations supporting cancer research 🧪🔬⚕️ I hope you'll find these useful to build our community here Pack 1: go.bsky.app/FEoaJMc Pack 2: go.bsky.app/6EcjWNA

I couldn't help myself, I did the thing. I'm sure people are missing (and/or are still arriving) - drop your name below, and I'll add you. #winnipeg go.bsky.app/Qj6c2ZG